Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ESSA Pharma Q4 EPS $(0.12) Up From $(0.14) YoY with Cash Balance of $148.1M and a Runway Likely to Fund its Planned Operations Through 2025

Author: Benzinga Newsdesk | December 12, 2023 08:05am
ESSA Pharma (NASDAQ:EPIX) reported quarterly losses of $(0.12) per share. This is a 14.29 percent increase over losses of $(0.14) per share from the same period last year.

Posted In: EPIX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist